Please provide your email address to receive an email when new articles are posted on . “The overall goal for patients and caregivers is a healthy and minimally traumatized access with longevity, few ...
To determine whether the lower rate of fistula use among obese patients is caused by reduced rates of fistula creation, or by elevated rates of primary or secondary fistula failure. Design and ...
Two devices for creating minimally invasive dialysis access--the Ellipsys ® Vascular Access System and the WavelinQ™ 4F System--demonstrated high rates of technical success and low rates of ...
San Juan Capistrano, Calif.--Two devices for creating minimally invasive dialysis access--the Ellipsys® Vascular Access System and the WavelinQ™ 4F System--demonstrated high rates of technical success ...
San Juan Capistrano, Calif. - A landmark two-year follow-up study on the Ellipsys® Vascular Access System was highlighted at the annual Controversies in Dialysis Access (CiDA) meeting, one of the ...
In a related press release, lead author Gerald A. Beathard, MD, PhD, of the University of Texas Medical Branch, said, “The dramatic difference in durability between the endovascular fistulas and the ...
Austin, Texas-based TVA Medical received FDA de novo marketing approval for its everlinQ endoAVF System. 1. Using magnetic catheters and radiofrequency energy, the everlinQ endoAVF system creates an ...
Fish oil, aspirin not effective for AVF failure treatment The study suggests that neither fish oil nor aspirin can be recommended for the prevention of AVF failure. For reducing arteriovenous fistula ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback